"We are focused on the potential FDA approval for CARDAMYST and the opportunity to help the millions of patients suffering from PSVT,” said Joseph Oliveto, President and Chief Executive Officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback